Fogelman I
Eur J Nucl Med. 1980 Dec;5(6):473-6. doi: 10.1007/BF00252034.
The diphosphonates are currently the skeletal imaging agents of choice and while extremely sensitive for bony abnormality their mechanism of action remains poorly understood. The current concepts in bone uptake mechanisms are reviewed and it is concluded that diphosphonate uptake is most likely related to sites of newly forming bone with diphosphonate adsorbed onto the surface of hydroxyapatite crystals. In situations where there is markedly increased skeletal uptake of tracer, increased vascularity alone cannot account for changes in tracer uptake and changes in skeletal extraction, related to newly forming bone are more important.
双膦酸盐目前是骨骼成像的首选药物,虽然它们对骨异常极为敏感,但其作用机制仍知之甚少。本文综述了目前关于骨摄取机制的概念,并得出结论:双膦酸盐的摄取很可能与新形成骨的部位有关,双膦酸盐吸附在羟基磷灰石晶体表面。在示踪剂骨骼摄取明显增加的情况下,仅血管增多并不能解释示踪剂摄取的变化,与新形成骨相关的骨骼摄取变化更为重要。